Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Infrainguinal Plug Technique Safe for Hernia Repair

By HospiMedica International staff writers
Posted on 16 Dec 2014
A new study suggests that repair of femoral hernias (FHs) using an infrainguinal plug technique is a simple and effective procedure, without major postoperative events.

Researchers at West China Hospital of Sichuan University (Chengdu, China) conducted a study of the UltraPro Plug (UPP) hernia repair device. More...
The study included a total of 121 patients (105 females, mean age 57.6 years) who underwent a total of 125 elective FH repairs with the UPP between March 2009 and March 2013. Median follow-up was 26 months, and the total follow-up rate was 91%. The researchers assessed demographics, surgical information, and outcomes.

The results showed that FHs occurred more often on the right (72) than the left (45), and in four patients the hernias were bilateral. Mean duration of hernia surgery was 14.7 minutes, and 91% of patients were discharged within 24 hours. The mean time to complete return to daily activities was 7.4 days, and no mortality or major complications occurred during the perioperative period. No recurrence or chronic mesh infection was noted. Postoperative chronic pain in two patients, sensory loss in one patient, and foreign body sensation in three patients were found in the follow-up. The study was published in the December 2014 issue of the Journal of Surgical Research.

“The infrainguinal plug technique for femoral hernia has gained popularity for its feasibility, simplicity, and encouraging rate of success, but materials and structures of traditional mesh plugs may cause postoperative discomfort, plug migration, and even recurrence,” concluded lead author Yinghan Song, PhD, and colleagues of the department of gastrointestinal surgery. “This study suggests that repair of femoral hernias with UPP through an infrainguinal approach is a simple and effective procedure without major postoperative events.”

The UPP device, a product of Ethicon (Somerville, NJ, USA), is a partially absorbable plug-and-patch device with a design that provides stability in the defect to minimize the risk of migration. The sterile, thermoformed plug is composed of a non-absorbable mesh and manufactured using three dimensional (3D) warp knitting technology. The non-absorbable part is made from polypropylene monofilament fibers, while the absorbable mesh made of poliglecaprone 25 monofilament fibers; both parts are connected by poliglecaprone 25 monofilament fibers.

Related Links:

West China Hospital of Sichuan University
Ethicon



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.